AstraZeneca Pharmaceuticals Lynparza (olaparib) capsules 50 mg, 112 count bottles recall — FDA D-0585-2018
Failed Impurities/Degradation Specifications; elevated levels of quality attribute Form L (polymorph).
Overview of recall records associated with AstraZeneca Pharmaceuticals LP, including dates, categories and classifications where available.
Classification mix: Class III: 1.
Failed Impurities/Degradation Specifications; elevated levels of quality attribute Form L (polymorph).
This page summarizes recall records in which the official source identifies AstraZeneca Pharmaceuticals LP as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.